Selected research
Market Structure
Global Yeast Expression Vector Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Yeast Expression Vector market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Yeast Expression Vector is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Yeast Expression Vector is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Yeast Expression Vector is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Yeast Expression Vector is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Yeast Expression Vector include Thermo Fisher Scientific, Inc. (US), Sigma-Aldrich Corporation (US), QIAGEN (Netherlands), Promega Corporation (US), New England Biolabs (US), Merck Millipore (US), GenScript USA Inc. (US), DNA2.0 (US) and Clontech Laboratories, Inc. (US), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Yeast Expression Vector market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Yeast Expression Vector and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Yeast Expression Vector sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Yeast Expression Vector market size, projected growth trends, production technologies, key applications, and end-use industries.
Yeast Expression Vector Segment by Company
Thermo Fisher Scientific, Inc. (US)
Sigma-Aldrich Corporation (US)
QIAGEN (Netherlands)
Promega Corporation (US)
New England Biolabs (US)
Merck Millipore (US)
GenScript USA Inc. (US)
DNA2.0 (US)
Clontech Laboratories, Inc. (US)
Bio-Rad Laboratories (US)
Agilent Technologies (US)
Yeast Expression Vector Segment by Type
Saccharomyces Cerevisiae Expression Vectors
Pichia Pastoris Expression Vectors
K. Lactis Expression Vectors
Others
Yeast Expression Vector Segment by Application
Industrial
Research
Therapeutic
Yeast Expression Vector Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Yeast Expression Vector market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Yeast Expression Vector and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Yeast Expression Vector.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Yeast Expression Vector market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Yeast Expression Vector manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Yeast Expression Vector in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Yeast Expression Vector in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Saccharomyces Cerevisiae Expression Vectors
- Pichia Pastoris Expression Vectors
- K. Lactis Expression Vectors
- Others
Applications
- Industrial
- Research
- Therapeutic
Companies covered
- Thermo Fisher Scientific, Inc. (US)
- Sigma-Aldrich Corporation (US)
- QIAGEN (Netherlands)
- Promega Corporation (US)
- New England Biolabs (US)
- Merck Millipore (US)
- GenScript USA Inc. (US)
- DNA2.0 (US)
- Clontech Laboratories, Inc. (US)
- Bio-Rad Laboratories (US)
- Agilent Technologies (US)
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Yeast Expression Vector Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Yeast Expression Vector Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Yeast Expression Vector Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Yeast Expression Vector Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Yeast Expression Vector Market Dynamics
- 2.1 Yeast Expression Vector Industry Trends
- 2.2 Yeast Expression Vector Industry Drivers
- 2.3 Yeast Expression Vector Industry Opportunities and Challenges
- 2.4 Yeast Expression Vector Industry Restraints
3 Yeast Expression Vector Market by Manufacturers
- 3.1 Global Yeast Expression Vector Revenue by Manufacturers (2021-2026)
- 3.2 Global Yeast Expression Vector Sales by Manufacturers (2021-2026)
- 3.3 Global Yeast Expression Vector Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Yeast Expression Vector Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Yeast Expression Vector Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Yeast Expression Vector Manufacturers, Product Type & Application
- 3.7 Global Yeast Expression Vector Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Yeast Expression Vector Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Yeast Expression Vector Players Market Share by Revenue in 2025
- 3.8.3 2025 Yeast Expression Vector Tier 1, Tier 2, and Tier 3
4 Yeast Expression Vector Market by Type
- 4.1 Yeast Expression Vector Type Introduction
- 4.1.1 Saccharomyces Cerevisiae Expression Vectors
- 4.1.2 Pichia Pastoris Expression Vectors
- 4.1.3 K. Lactis Expression Vectors
- 4.1.4 Others
- 4.2 Global Yeast Expression Vector Sales by Type
- 4.2.1 Global Yeast Expression Vector Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Yeast Expression Vector Sales by Type (2021-2032)
- 4.2.3 Global Yeast Expression Vector Sales Market Share by Type (2021-2032)
- 4.3 Global Yeast Expression Vector Revenue by Type
- 4.3.1 Global Yeast Expression Vector Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Yeast Expression Vector Revenue by Type (2021-2032)
- 4.3.3 Global Yeast Expression Vector Revenue Market Share by Type (2021-2032)
5 Yeast Expression Vector Market by Application
- 5.1 Yeast Expression Vector Application Introduction
- 5.1.1 Industrial
- 5.1.2 Research
- 5.1.3 Therapeutic
- 5.2 Global Yeast Expression Vector Sales by Application
- 5.2.1 Global Yeast Expression Vector Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Yeast Expression Vector Sales by Application (2021-2032)
- 5.2.3 Global Yeast Expression Vector Sales Market Share by Application (2021-2032)
- 5.3 Global Yeast Expression Vector Revenue by Application
- 5.3.1 Global Yeast Expression Vector Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Yeast Expression Vector Revenue by Application (2021-2032)
- 5.3.3 Global Yeast Expression Vector Revenue Market Share by Application (2021-2032)
6 Global Yeast Expression Vector Sales by Region
- 6.1 Global Yeast Expression Vector Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Yeast Expression Vector Sales by Region (2021-2032)
- 6.2.1 Global Yeast Expression Vector Sales by Region (2021-2026)
- 6.2.2 Global Yeast Expression Vector Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Yeast Expression Vector Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Yeast Expression Vector Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Yeast Expression Vector Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Yeast Expression Vector Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Yeast Expression Vector Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Yeast Expression Vector Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Yeast Expression Vector Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Yeast Expression Vector Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Yeast Expression Vector Revenue by Region
- 7.1 Global Yeast Expression Vector Revenue by Region
- 7.1.1 Global Yeast Expression Vector Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Yeast Expression Vector Revenue by Region (2021-2026)
- 7.1.3 Global Yeast Expression Vector Revenue by Region (2027-2032)
- 7.1.4 Global Yeast Expression Vector Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Yeast Expression Vector Revenue (2021-2032)
- 7.2.2 North America Yeast Expression Vector Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Yeast Expression Vector Revenue (2021-2032)
- 7.3.2 Europe Yeast Expression Vector Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Yeast Expression Vector Revenue (2021-2032)
- 7.4.2 Asia-Pacific Yeast Expression Vector Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Yeast Expression Vector Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Yeast Expression Vector Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Thermo Fisher Scientific, Inc. (US)
- 8.1.1 Thermo Fisher Scientific, Inc. (US) Company Information
- 8.1.2 Thermo Fisher Scientific, Inc. (US) Business Overview
- 8.1.3 Thermo Fisher Scientific, Inc. (US) Yeast Expression Vector Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Thermo Fisher Scientific, Inc. (US) Yeast Expression Vector Product Portfolio
- 8.1.5 Thermo Fisher Scientific, Inc. (US) Recent Developments
- 8.2 Sigma-Aldrich Corporation (US)
- 8.2.1 Sigma-Aldrich Corporation (US) Company Information
- 8.2.2 Sigma-Aldrich Corporation (US) Business Overview
- 8.2.3 Sigma-Aldrich Corporation (US) Yeast Expression Vector Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Sigma-Aldrich Corporation (US) Yeast Expression Vector Product Portfolio
- 8.2.5 Sigma-Aldrich Corporation (US) Recent Developments
- 8.3 QIAGEN (Netherlands)
- 8.3.1 QIAGEN (Netherlands) Company Information
- 8.3.2 QIAGEN (Netherlands) Business Overview
- 8.3.3 QIAGEN (Netherlands) Yeast Expression Vector Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 QIAGEN (Netherlands) Yeast Expression Vector Product Portfolio
- 8.3.5 QIAGEN (Netherlands) Recent Developments
- 8.4 Promega Corporation (US)
- 8.4.1 Promega Corporation (US) Company Information
- 8.4.2 Promega Corporation (US) Business Overview
- 8.4.3 Promega Corporation (US) Yeast Expression Vector Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Promega Corporation (US) Yeast Expression Vector Product Portfolio
- 8.4.5 Promega Corporation (US) Recent Developments
- 8.5 New England Biolabs (US)
- 8.5.1 New England Biolabs (US) Company Information
- 8.5.2 New England Biolabs (US) Business Overview
- 8.5.3 New England Biolabs (US) Yeast Expression Vector Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 New England Biolabs (US) Yeast Expression Vector Product Portfolio
- 8.5.5 New England Biolabs (US) Recent Developments
- 8.6 Merck Millipore (US)
- 8.6.1 Merck Millipore (US) Company Information
- 8.6.2 Merck Millipore (US) Business Overview
- 8.6.3 Merck Millipore (US) Yeast Expression Vector Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Merck Millipore (US) Yeast Expression Vector Product Portfolio
- 8.6.5 Merck Millipore (US) Recent Developments
- 8.7 GenScript USA Inc. (US)
- 8.7.1 GenScript USA Inc. (US) Company Information
- 8.7.2 GenScript USA Inc. (US) Business Overview
- 8.7.3 GenScript USA Inc. (US) Yeast Expression Vector Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 GenScript USA Inc. (US) Yeast Expression Vector Product Portfolio
- 8.7.5 GenScript USA Inc. (US) Recent Developments
- 8.8 DNA2.0 (US)
- 8.8.1 DNA2.0 (US) Company Information
- 8.8.2 DNA2.0 (US) Business Overview
- 8.8.3 DNA2.0 (US) Yeast Expression Vector Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 DNA2.0 (US) Yeast Expression Vector Product Portfolio
- 8.8.5 DNA2.0 (US) Recent Developments
- 8.9 Clontech Laboratories, Inc. (US)
- 8.9.1 Clontech Laboratories, Inc. (US) Company Information
- 8.9.2 Clontech Laboratories, Inc. (US) Business Overview
- 8.9.3 Clontech Laboratories, Inc. (US) Yeast Expression Vector Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Clontech Laboratories, Inc. (US) Yeast Expression Vector Product Portfolio
- 8.9.5 Clontech Laboratories, Inc. (US) Recent Developments
- 8.10 Bio-Rad Laboratories (US)
- 8.10.1 Bio-Rad Laboratories (US) Company Information
- 8.10.2 Bio-Rad Laboratories (US) Business Overview
- 8.10.3 Bio-Rad Laboratories (US) Yeast Expression Vector Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Bio-Rad Laboratories (US) Yeast Expression Vector Product Portfolio
- 8.10.5 Bio-Rad Laboratories (US) Recent Developments
- 8.11 Agilent Technologies (US)
- 8.11.1 Agilent Technologies (US) Company Information
- 8.11.2 Agilent Technologies (US) Business Overview
- 8.11.3 Agilent Technologies (US) Yeast Expression Vector Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Agilent Technologies (US) Yeast Expression Vector Product Portfolio
- 8.11.5 Agilent Technologies (US) Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Yeast Expression Vector Value Chain Analysis
- 9.1.1 Yeast Expression Vector Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Yeast Expression Vector Production Mode & Process
- 9.2 Yeast Expression Vector Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Yeast Expression Vector Distributors
- 9.2.3 Yeast Expression Vector Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst